1	Impaired	Impaired	B-NP	JJ	O	5	NMOD	0
2	coronary	coronary	I-NP	JJ	O	5	NMOD	0
3	collateral	collateral	I-NP	NN	O	5	NMOD	0
4	vessel	vessel	I-NP	NN	O	5	NMOD	0
5	development	development	I-NP	NN	O	0	ROOT	2	development
6	in	in	B-PP	IN	O	5	NMOD	0
7	patients	patient	B-NP	NNS	O	6	PMOD	0
8	with	with	B-PP	IN	O	7	NMOD	0
9	proliferative	proliferative	B-NP	JJ	O	11	NMOD	0
10	diabetic	diabetic	I-NP	JJ	O	11	NMOD	0
11	retinopathy	retinopathy	I-NP	NN	O	8	PMOD	0
12	.	.	O	.	O	5	P	0

1	BACKGROUND	BACKGROUND	B-NP	NN	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Diabetic	Diabetic	B-NP	JJ	O	4	NMOD	0
4	patients	patient	I-NP	NNS	O	5	SUB	0
5	have	have	B-VP	VBP	O	1	NMOD	0
6	been	be	I-VP	VBN	O	5	VC	0
7	reported	report	I-VP	VBN	O	6	VC	0
8	to	to	I-VP	TO	O	9	VMOD	0
9	have	have	I-VP	VB	O	7	VMOD	0
10	impaired	impair	I-VP	VBN	O	9	VMOD	0
11	coronary	coronary	B-NP	JJ	O	14	NMOD	0
12	collateral	collateral	I-NP	NN	O	14	NMOD	0
13	vessel	vessel	I-NP	NN	O	14	NMOD	0
14	growth	growth	I-NP	NN	O	10	OBJ	4	growth
15	,	,	O	,	O	5	P	0
16	although	although	B-SBAR	IN	O	5	VMOD	0
17	they	they	B-NP	PRP	O	18	SUB	0
18	have	have	B-VP	VBP	O	16	SBAR	0
19	excessive	excessive	B-NP	JJ	O	20	NMOD	0
20	neovascularization	neovascularization	I-NP	NN	O	18	OBJ	3	neovascularization
21	in	in	B-PP	IN	O	18	VMOD	0
22	the	the	B-NP	DT	O	23	NMOD	0
23	retina	retina	I-NP	NN	O	21	PMOD	0
24	.	.	O	.	O	1	P	0

1	HYPOTHESIS	HYPOTHESIS	B-NP	NN	O	4	NMOD	0
2	:	:	O	:	O	1	P	0
3	This	This	B-NP	DT	O	4	NMOD	0
4	study	study	I-NP	NN	O	5	SUB	0
5	was	be	B-VP	VBD	O	0	ROOT	0
6	designed	design	I-VP	VBN	O	5	VC	0
7	to	to	B-VP	TO	O	8	VMOD	0
8	compare	compare	I-VP	VB	O	6	VMOD	0
9	coronary	coronary	B-NP	JJ	O	11	NMOD	0
10	collateral	collateral	I-NP	NN	O	11	NMOD	0
11	circulation	circulation	I-NP	NN	O	8	OBJ	0
12	(	(	O	(	O	14	DEP	0
13	CCC	CCC	B-NP	NN	O	14	DEP	0
14	)	)	O	)	O	11	NMOD	0
15	in	in	B-PP	IN	O	11	NMOD	0
16	patients	patient	B-NP	NNS	O	15	PMOD	0
17	with	with	B-PP	IN	O	16	NMOD	0
18	proliferative	proliferative	B-NP	JJ	O	20	NMOD	0
19	diabetic	diabetic	I-NP	JJ	O	20	NMOD	0
20	retinopathy	retinopathy	I-NP	NN	O	17	PMOD	0
21	(	(	O	(	O	23	DEP	0
22	PDR	PDR	B-NP	NN	B-protein	23	DEP	0
23	)	)	O	)	O	20	NMOD	0
24	with	with	B-PP	IN	O	16	NMOD	0
25	that	that	B-NP	DT	O	24	PMOD	0
26	in	in	B-PP	IN	O	25	NMOD	0
27	patients	patient	B-NP	NNS	O	26	PMOD	0
28	without	without	B-PP	IN	O	27	NMOD	0
29	DR	DR	B-NP	NN	B-protein	28	PMOD	0
30	.	.	O	.	O	5	P	0

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Ninety	Ninety	B-NP	CD	O	5	NMOD	0
4	diabetic	diabetic	I-NP	JJ	O	5	NMOD	0
5	patients	patient	I-NP	NNS	O	18	SUB	0
6	with	with	B-PP	IN	O	5	NMOD	0
7	chronic	chronic	B-NP	JJ	O	9	NMOD	0
8	total	total	I-NP	JJ	O	9	NMOD	0
9	occlusion	occlusion	I-NP	NN	O	6	PMOD	0
10	in	in	B-PP	IN	O	5	NMOD	0
11	at	at	B-NP	IN	O	14	NMOD	0
12	least	least	I-NP	JJS	O	11	AMOD	0
13	one	one	I-NP	CD	O	11	AMOD	0
14	major	major	I-NP	JJ	O	10	PMOD	0
15	epicardial	epicardial	I-NP	JJ	O	17	NMOD	0
16	coronary	coronary	I-NP	JJ	O	17	NMOD	0
17	artery	artery	I-NP	NN	O	14	NMOD	0
18	were	be	B-VP	VBD	O	1	NMOD	0
19	enrolled	enrol	I-VP	VBN	O	18	VC	0
20	in	in	B-PP	IN	O	19	VMOD	0
21	the	the	B-NP	DT	O	22	NMOD	0
22	study	study	I-NP	NN	O	20	PMOD	0
23	.	.	O	.	O	1	P	0

1	Groups	Group	B-NP	NNS	O	5	SUB	0
2	1	1	I-NP	CD	O	4	NMOD	0
3	and	and	I-NP	CC	O	4	NMOD	0
4	2	2	I-NP	CD	O	1	NMOD	0
5	consisted	consist	B-VP	VBD	O	0	ROOT	0
6	of	of	B-PP	IN	O	5	VMOD	0
7	48	48	B-NP	CD	O	8	NMOD	0
8	patients	patient	I-NP	NNS	O	6	PMOD	0
9	without	without	B-PP	IN	O	5	VMOD	0
10	DR	DR	B-NP	NN	O	13	NMOD	0
11	and	and	O	CC	O	13	NMOD	0
12	42	42	B-NP	CD	O	13	NMOD	0
13	patients	patient	I-NP	NNS	O	9	PMOD	0
14	with	with	B-PP	IN	O	13	NMOD	0
15	PDR	PDR	B-NP	NN	O	14	PMOD	0
16	,	,	O	,	O	5	P	0
17	respectively	respectively	B-ADVP	RB	O	5	VMOD	0
18	.	.	O	.	O	5	P	0

1	Coronary	Coronary	B-NP	JJ	O	3	NMOD	0
2	collateral	collateral	I-NP	NN	O	3	NMOD	0
3	circulation	circulation	I-NP	NN	O	7	SUB	0
4	(	(	O	(	O	6	DEP	0
5	CCC	CCC	B-NP	NN	O	6	DEP	0
6	)	)	O	)	O	3	NMOD	0
7	was	be	B-VP	VBD	O	0	ROOT	0
8	analyzed	analyze	I-VP	VBN	O	7	VC	0
9	according	accord	B-PP	VBG	O	8	VMOD	0
10	to	to	B-PP	TO	O	9	PMOD	0
11	the	the	B-NP	DT	O	13	NMOD	0
12	Rentrop	Rentrop	I-NP	NNP	O	13	NMOD	0
13	system	system	I-NP	NN	O	10	PMOD	0
14	.	.	O	.	O	7	P	0

1	Each	Each	B-NP	DT	O	2	NMOD	0
2	group	group	I-NP	NN	O	3	SUB	0
3	was	be	B-VP	VBD	O	0	ROOT	0
4	also	also	I-VP	RB	O	3	VMOD	0
5	divided	divide	I-VP	VBN	O	3	VC	0
6	into	into	B-PP	IN	O	5	VMOD	0
7	two	two	B-NP	CD	O	8	NMOD	0
8	subgroups	subgroup	I-NP	NNS	O	6	PMOD	0
9	according	accord	B-PP	VBG	O	8	NMOD	0
10	to	to	B-PP	TO	O	9	PMOD	0
11	poor	poor	B-NP	JJ	O	14	NMOD	0
12	and	and	I-NP	CC	O	14	NMOD	0
13	good	good	I-NP	JJ	O	14	NMOD	0
14	CCC	CCC	I-NP	NN	O	10	PMOD	0
15	.	.	O	.	O	3	P	0

1	Serum	Serum	B-NP	NN	B-protein	5	NMOD	0
2	vascular	vascular	I-NP	JJ	I-protein	5	NMOD	0
3	endothelial	endothelial	I-NP	JJ	I-protein	5	NMOD	0
4	growth	growth	I-NP	NN	I-protein	5	NMOD	0
5	factor	factor	I-NP	NN	I-protein	9	NMOD	0
6	(	(	O	(	O	8	DEP	0
7	VEGF	VEGF	B-NP	NN	B-protein	8	DEP	0
8	)	)	O	)	O	5	NMOD	0
9	levels	level	B-NP	NNS	O	10	SUB	0
10	were	be	B-VP	VBD	O	0	ROOT	0
11	measured	measure	I-VP	VBN	O	10	VC	0
12	using	use	B-VP	VBG	O	10	VMOD	0
13	the	the	B-NP	DT	O	16	NMOD	0
14	enzyme-linked	enzyme-linked	I-NP	JJ	O	16	NMOD	0
15	immunosorbent	immunosorbent	I-NP	JJ	O	16	NMOD	0
16	assay	assay	I-NP	NN	O	20	NMOD	0
17	(	(	O	(	O	19	DEP	0
18	ELISA	ELISA	B-NP	NN	O	19	DEP	0
19	)	)	O	)	O	16	NMOD	0
20	kit	kit	B-NP	NN	O	12	OBJ	0
21	.	.	O	.	O	10	P	0

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	The	The	B-NP	DT	O	7	NMOD	0
4	mean	mean	I-NP	JJ	O	7	NMOD	0
5	Rentrop	Rentrop	I-NP	NNP	O	7	NMOD	0
6	collateral	collateral	I-NP	NN	O	7	NMOD	0
7	score	score	I-NP	NN	O	8	SUB	0
8	was	be	B-VP	VBD	O	1	NMOD	0
9	higher	high	B-ADJP	JJR	O	8	PRD	0
10	in	in	B-PP	IN	O	9	AMOD	0
11	Group	Group	B-NP	NN	O	10	PMOD	0
12	1	1	I-NP	CD	O	11	NMOD	0
13	than	than	B-PP	IN	O	9	AMOD	0
14	in	in	B-PP	IN	O	13	PMOD	0
15	Group	Group	B-NP	NN	O	14	PMOD	0
16	2	2	I-NP	CD	O	15	NMOD	0
17	(	(	O	(	O	32	DEP	0
18	2.39	2.39	B-NP	CD	O	24	NMOD	0
19	+/-	+/-	O	SYM	O	24	NMOD	0
20	1.07	1.07	B-NP	CD	O	24	NMOD	0
21	vs.	vs.	B-PP	IN	O	24	NMOD	0
22	1.76	1.76	B-NP	CD	O	24	NMOD	0
23	+/-	+/-	I-NP	SYM	O	24	NMOD	0
24	0.76	0.76	I-NP	CD	O	28	NMOD	0
25	,	,	O	,	O	24	P	0
26	respectively	respectively	B-ADVP	RB	O	24	NMOD	0
27	,	,	O	,	O	28	P	0
28	p	p	B-NP	NN	O	32	DEP	0
29	less	less	B-ADJP	JJR	O	28	NMOD	0
30	than	than	B-PP	IN	O	29	AMOD	0
31	0.001	0.001	B-NP	CD	O	30	PMOD	0
32	)	)	O	)	O	9	AMOD	0
33	.	.	O	.	O	1	P	0

1	When	When	B-ADVP	WRB	O	17	VMOD	0
2	the	the	B-NP	DT	O	4	NMOD	0
3	two	two	I-NP	CD	O	4	NMOD	0
4	groups	group	I-NP	NNS	O	5	SUB	0
5	were	be	B-VP	VBD	O	1	SBAR	0
6	compared	compare	I-VP	VBN	O	5	VC	0
7	with	with	B-PP	IN	O	6	VMOD	0
8	respect	respect	B-NP	NN	O	7	PMOD	0
9	to	to	B-PP	TO	O	8	NMOD	0
10	poor	poor	B-NP	JJ	O	12	AMOD	0
11	and	and	I-NP	CC	O	12	AMOD	0
12	good	good	I-NP	JJ	O	16	NMOD	0
13	CCC	CCC	I-NP	NN	O	16	NMOD	0
14	,	,	O	,	O	16	P	0
15	poor	poor	B-NP	JJ	O	16	NMOD	0
16	CCC	CCC	I-NP	NN	O	9	PMOD	0
17	was	be	B-VP	VBD	O	0	ROOT	0
18	higher	high	B-ADJP	JJR	O	17	PRD	0
19	in	in	B-PP	IN	O	18	AMOD	0
20	patients	patient	B-NP	NNS	O	19	PMOD	0
21	with	with	B-PP	IN	O	20	NMOD	0
22	PDR	PDR	B-NP	NN	O	21	PMOD	0
23	(	(	O	(	O	34	DEP	0
24	64	64	B-NP	CD	O	27	NMOD	0
25	vs.	vs.	B-PP	IN	O	27	NMOD	0
26	36	36	B-NP	CD	O	27	NMOD	0
27	%	%	I-NP	NN	O	34	DEP	0
28	,	,	O	,	O	27	P	0
29	respectively	respectively	B-ADVP	RB	O	27	NMOD	0
30	,	,	O	,	O	34	P	0
31	p	p	B-NP	NN	O	34	DEP	0
32	=	=	B-VP	SYM	O	31	NMOD	0
33	0.01	0.01	B-NP	CD	O	32	AMOD	0
34	)	)	O	)	O	22	NMOD	0
35	.	.	O	.	O	17	P	0

1	Serum	Serum	B-NP	NN	B-protein	3	NMOD	0
2	VEGF	VEGF	I-NP	NN	I-protein	3	NMOD	0
3	levels	level	I-NP	NNS	O	4	SUB	0
4	were	be	B-VP	VBD	O	39	VMOD	0
5	higher	high	B-ADJP	JJR	O	4	PRD	0
6	in	in	B-PP	IN	O	5	AMOD	0
7	patients	patient	B-NP	NNS	O	6	PMOD	0
8	with	with	B-PP	IN	O	7	NMOD	0
9	PDR	PDR	B-NP	NN	B-protein	8	PMOD	0
10	than	than	B-PP	IN	O	5	AMOD	0
11	in	in	B-PP	IN	O	10	PMOD	0
12	those	those	B-NP	DT	O	11	PMOD	0
13	without	without	B-PP	IN	O	12	NMOD	0
14	DR	DR	B-NP	NN	O	13	PMOD	0
15	(	(	O	(	O	29	DEP	0
16	219	219	B-NP	CD	O	18	AMOD	0
17	+/-	+/-	I-NP	SYM	O	18	AMOD	0
18	99	99	I-NP	CD	O	23	NMOD	0
19	vs.	vs.	B-PP	IN	O	23	NMOD	0
20	139	139	B-NP	CD	O	22	AMOD	0
21	+/-	+/-	I-NP	SYM	O	22	AMOD	0
22	98	98	I-NP	CD	O	23	NMOD	0
23	pg/ml	pg/ml	I-NP	NN	O	25	NMOD	0
24	,	,	O	,	O	25	P	0
25	p	p	B-NP	NN	O	27	SUB	0
26	less	less	B-ADJP	JJR	O	27	AMOD	0
27	than	than	B-PP	IN	O	29	DEP	0
28	0.001	0.001	B-NP	CD	O	27	AMOD	0
29	)	)	O	)	O	12	NMOD	0
30	;	;	O	:	O	39	P	0
31	however	however	B-ADVP	RB	O	39	VMOD	0
32	,	,	O	,	O	39	P	0
33	patients	patient	B-NP	NNS	O	39	SUB	0
34	with	with	B-PP	IN	O	33	NMOD	0
35	poor	poor	B-NP	JJ	O	37	AMOD	0
36	and	and	I-NP	CC	O	37	AMOD	0
37	good	good	I-NP	JJ	O	38	NMOD	0
38	CCC	CCC	I-NP	NN	O	34	PMOD	0
39	had	have	B-VP	VBD	O	0	ROOT	0
40	similar	similar	B-NP	JJ	O	42	NMOD	0
41	VEGF	VEGF	I-NP	NN	B-protein	42	NMOD	0
42	levels	level	I-NP	NNS	O	39	OBJ	0
43	.	.	O	.	O	39	P	0

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	We	We	B-NP	PRP	O	4	SUB	0
4	have	have	B-VP	VBP	O	1	NMOD	0
5	shown	show	I-VP	VBN	O	4	VC	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	patients	patient	B-NP	NNS	O	10	SUB	0
8	with	with	B-PP	IN	O	7	NMOD	0
9	PDR	PDR	B-NP	NN	B-protein	8	PMOD	0
10	have	have	B-VP	VBP	O	6	SBAR	0
11	a	a	B-NP	DT	O	15	NMOD	0
12	lower	low	I-NP	JJR	O	15	NMOD	0
13	coronary	coronary	I-NP	JJ	O	15	NMOD	0
14	collateral	collateral	I-NP	NN	O	15	NMOD	0
15	score	score	I-NP	NN	O	10	OBJ	0
16	than	than	B-PP	IN	O	15	NMOD	0
17	patients	patient	B-NP	NNS	O	16	PMOD	0
18	without	without	B-PP	IN	O	17	NMOD	0
19	DR	DR	B-NP	NN	B-protein	18	PMOD	0
20	.	.	O	.	O	1	P	0

1	Also	Also	B-ADVP	RB	O	5	VMOD	0
2	,	,	O	,	O	5	P	0
3	serum	serum	B-NP	NN	B-protein	4	NMOD	0
4	VEGF	VEGF	I-NP	NN	I-protein	5	SUB	0
5	was	be	B-VP	VBD	O	0	ROOT	0
6	significantly	significantly	B-ADJP	RB	O	7	AMOD	0
7	higher	high	I-ADJP	JJR	O	5	PRD	0
8	in	in	B-PP	IN	O	7	AMOD	0
9	patients	patient	B-NP	NNS	O	8	PMOD	0
10	with	with	B-PP	IN	O	9	NMOD	0
11	PDR	PDR	B-NP	NN	B-protein	10	PMOD	0
12	than	than	B-PP	IN	O	7	AMOD	0
13	in	in	B-PP	IN	O	12	PMOD	0
14	those	those	B-NP	DT	O	13	PMOD	0
15	without	without	B-PP	IN	O	14	NMOD	0
16	DR	DR	B-NP	NN	B-protein	15	PMOD	0
17	.	.	O	.	O	5	P	0

1	These	These	B-NP	DT	O	2	NMOD	0
2	findings	finding	I-NP	NNS	O	3	SUB	0
3	have	have	B-VP	VBP	O	0	ROOT	0
4	suggested	suggest	I-VP	VBN	O	3	VC	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	diabetes	diabetes	B-NP	NN	O	7	NMOD	0
7	mellitus	mellitus	I-NP	NN	O	8	SUB	0
8	may	may	B-VP	MD	O	5	SBAR	0
9	have	have	I-VP	VB	O	8	VC	0
10	a	a	B-NP	DT	O	12	NMOD	0
11	different	different	I-NP	JJ	O	12	NMOD	0
12	action	action	I-NP	NN	O	9	OBJ	0
13	on	on	B-PP	IN	O	9	VMOD	0
14	retinal	retinal	B-NP	JJ	O	17	NMOD	0
15	and	and	I-NP	CC	O	17	NMOD	0
16	coronary	coronary	I-NP	JJ	O	17	NMOD	0
17	circulation	circulation	I-NP	NN	O	13	PMOD	0
18	.	.	O	.	O	3	P	0

